|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, July 12, 2008 ) Denver, CO - LegalView, the most comprehensive legal resource available on the Web, released details of a newly advertised clinical trial that will target radiation and chemotherapy treatments rather than surgery for mesothelioma patients. The study is for individuals suffering from malignant pleural mesothelioma, which is often considered the most deadly form of mesothelioma cancer. The trial will take approximately 13 weeks and will involve exploratory surgery as well as chemotherapy and radiotherapy, which will be administered directly into the affected area.
Mesothelioma cancer is caused by the inhalation of asbestos fibers and dust, which can occur anywhere asbestos has been previously used, although it is most commonly found in insulation within the construction industry. Individuals who have been affected by mesothelioma cancer are advised to seek out a mesothelioma law firm (http://mesothelioma.legalview.com) that can provide victims with a better understanding of the details of a potential mesothelioma lawsuit (http://mesothelioma.legalview.com). An experienced law firm will also provide a plethora of mesothelioma lawyers (http://mesothelioma.legalview.com) to deal with the specifics of an individual's asbestos-related case.
The new clinical trial aims to find a successful alternative treatment to surgery. Currently, mesothelioma cancer has a grim prognosis, as it is usually not successfully treatable and most often the cancerous portions of the lung are removed via a surgical procedure, which doesn't commonly provide a prolonged life for victims. Additionally, according to the details of the study, surgery "may even lead to a worsened pulmonary function" among patients. For more information on developing litigation related to mesothelioma and asbestos, individuals should locate a mesothelioma attorney (http://mesothelioma.legalview.com) who can provide legal consultation on the details of an individual victim's lawsuit.
For information on locating an experienced lawyer, visit LegalView's homepage, which also offers additional information on an array of legal topics including the heavily discussed pharmaceutical controversies that have recently threatened patients. For example, prescription drugs such as Levaquin, Avandia and Chantix have become hot topics in many news reports for the alleged side effects and potential risks associated with each drug.
Levaquin is an anti-bacterial prescription drug that is part of the fluoroquinolone drug family. Levaquin is used for an array of conditions ranging from urinary tract infections to bronchitis to gonorrhea and Chlamydia to pneumonia. According to several scientific studies recently released, consumption of the drug may lead to Levaquin-induced Achilles tendonitis among patients who take the drug for short- to long-term periods of time. One study published in the Journal of the American Board of Family Medicine suggested that patients who had taken the drug anywhere from 6 months to two years and prior may even be at risk for the Levaquin tendon rupture (http://levaquin.legalview.com). Additionally Cipro, another of the fluoroquinolone drugs, has also been found to pose a potential risk for tendonitis and tendon rupture and has thus been given a "black box" Cipro FDA warning (http://cipro.legalview.com). The "black box warning is the strongest warning the FDA can put on a drug.
Finally, Chantix, one of the most recently released prescription drugs, is used to aid patients attempting to quit smoking. In late 2007, hundreds of patients of the smoking-cessation drug had reported unusual Chantix side effects (http://chantix.legalview.com) that included mood swings, erratic behavior, depression, suicidal thoughts and tendencies. An additional 37 cases of suicide among Chantix patients had also been reported to the FDA, according to an FDA Public Health Advisory from 2008. To learn more about these issues as well as many others, visit the LegalView homepage.
About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.
LegalView
Katie Kelley
720-771-3246
press-releases@legalview.com 
Source: EmailWire.com
|
|
|
|
